Beard, Stephen W.
Beard, Stephen W.'s purchase track record
Beard, Stephen W. has only 1 open-market purchase with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/9/2021 | CVSA | $33K | -14.2% | -4.0% | -14.6% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Planet Fitness shares rise as UBS calls AI risks manageable. Planet Fitness stock is up today after UBS stated that potential risks from Meta's AI agent to membership growth are manageable. This positive outlook follows a recent price target reduction by RBC Capital to $60. The stock is currently trading near its support level, with analysts maintaining a mixed but generally positive view on the company's valuation.
Transaction History
| CVSA | ▼ Sell | Open Market | 4,667 | $610K | 10/9/2026 | View on chart |
| CVSA | ▼ Sell | Open Market | 3,639 | $474K | 10/8/2026 | View on chart |
| PLNT | ▲ Buy | Grant | 522 | $0 | 10/1/2026 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 9,621 | $1.3M | 8/23/2026 | View on chart |
| CVSA | ▲ Buy | Grant | 53,144 | $7.0M | 8/23/2026 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 23,543 | $3.1M | 8/23/2026 | View on chart |
| CVSA | ▲ Buy | Grant | 75,920 | $10.0M | 8/23/2026 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 33,633 | $4.5M | 8/23/2026 | View on chart |
| CVSA | ▼ Sell | Open Market | 3,545 | $462K | 8/11/2026 | View on chart |
| CVSA | ▼ Sell | Open Market | 5,291 | $702K | 7/13/2026 | View on chart |
| PLNT | ▲ Buy | Grant | 332 | $0 | 7/1/2026 | View on chart |
| CVSA | ▼ Sell | Open Market | 2,529 | $331K | 6/11/2026 | View on chart |
| CVSA | ▼ Sell | Open Market | 2,762 | $359K | 6/10/2026 | View on chart |
| CVSA | ▼ Sell | Open Market | 15,874 | $2.1M | 5/8/2026 | View on chart |
| PLNT | ▲ Buy | Grant | 2,254 | $0 | 5/5/2026 | View on chart |
| PLNT | ▲ Buy | Grant | 139 | $0 | 4/1/2026 | View on chart |
| PLNT | ▲ Buy | Grant | 368 | $0 | 2/9/2026 | View on chart |
| CVSA | ▼ Sell | Gift | 5,332 | $0 | 12/10/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 9,204 | $886K | 11/13/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 12,943 | $1.8M | 9/8/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 8,906 | $1.2M | 8/24/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 53,417 | $7.2M | 8/24/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 120,578 | $16.3M | 8/24/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 151,052 | $20.4M | 8/23/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 66,905 | $9.0M | 8/23/2025 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 9,621 | $1.3M | 8/23/2025 | View on chart |
| CVSA | ▲ Buy | Grant | 62,330 | $5.6M | 11/13/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 12,937 | $903K | 9/8/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 1,787 | $135K | 8/26/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 8,918 | $672K | 8/24/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 7,991 | $602K | 8/23/2024 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 12,920 | $571K | 9/8/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 511 | $22K | 8/28/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 1,787 | $77K | 8/26/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 3,089 | $133K | 8/26/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 2,889 | $125K | 8/26/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 6,972 | $301K | 8/26/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 6,520 | $282K | 8/26/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 5,997 | $261K | 8/24/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 65,150 | $2.8M | 8/23/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 11,209 | $495K | 8/14/2023 | View on chart |
| CVSA | ▲ Buy | Grant | 31,875 | $1.4M | 8/14/2023 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 11,998 | $450K | 9/8/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 1,228 | $49K | 8/28/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 719 | $29K | 8/28/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 511 | $20K | 8/28/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 4,191 | $167K | 8/28/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 2,333 | $93K | 8/28/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 1,158 | $46K | 8/26/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 60,390 | $2.4M | 8/24/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 327 | $13K | 8/22/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 24,950 | $937K | 8/12/2022 | View on chart |
| CVSA | ▼ Sell | Other | 8,228 | $309K | 8/12/2022 | View on chart |
| CVSA | ▲ Buy | Grant | 18,470 | $544K | 3/21/2022 | View on chart |
| CVSA | ▼ Sell | Tax Withholding | 669 | $16K | 2/14/2022 | View on chart |
| CVSA | ▲ Buy | Open Market | 1,000 | $33K | 11/9/2021 | View on chart |
| CVSA | ▲ Buy | Grant | 116,860 | $4.4M | 9/8/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 10, 2026
Covista receives mixed analyst coverage and rating update
Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.
Covista receives mixed analyst coverage and rating update. Recent commentary on Covista is mixed. ChartMill describes the stock as a GARP case with reasonable growth and valuation. Yahoo published both a target‑focused piece and a separate article highlighting reasons to avoid the stock. BMO Capital kept an Outperform rating but lowered its price target to $145.